Studies have indicated that hesperidin can alleviate hepatic steatosis by activating the liver Pl3k/AKT-Nrf2 pathway [49], and fluoxetine may regulate glucose and lipid metabolism in diabetic rats through the PI3K-AKT signaling pathway [50]. This evidence concerns the gene AKT1 and Hepatic steatosis.